BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8530375)

  • 1. Chimeric molecules between keratinocyte growth factor and basic fibroblast growth factor define domains that confer receptor binding specificities.
    Reich-Slotky R; Shaoul E; Berman B; Graziani G; Ron D
    J Biol Chem; 1995 Dec; 270(50):29813-8. PubMed ID: 8530375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A keratinocyte growth factor receptor-derived peptide antagonist identifies part of the ligand binding site.
    Bottaro DP; Fortney E; Rubin JS; Aaronson SA
    J Biol Chem; 1993 May; 268(13):9180-3. PubMed ID: 8387485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of cell-associated heparan sulfates on the binding of keratinocyte growth factor (KGF) and acidic fibroblast growth factor to the KGF receptor.
    Reich-Slotky R; Bonneh-Barkay D; Shaoul E; Bluma B; Svahn CM; Ron D
    J Biol Chem; 1994 Dec; 269(51):32279-85. PubMed ID: 7528211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple structural elements determine ligand binding of fibroblast growth factor receptors. Evidence that both Ig domain 2 and 3 define receptor specificity.
    Zimmer Y; Givol D; Yayon A
    J Biol Chem; 1993 Apr; 268(11):7899-903. PubMed ID: 7681832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of recombinant human fibroblast growth factor (FGF)-10 reveals functional similarities with keratinocyte growth factor (FGF-7).
    Igarashi M; Finch PW; Aaronson SA
    J Biol Chem; 1998 May; 273(21):13230-5. PubMed ID: 9582367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparan sulfate proteoglycan modulates keratinocyte growth factor signaling through interaction with both ligand and receptor.
    LaRochelle WJ; Sakaguchi K; Atabey N; Cheon HG; Takagi Y; Kinaia T; Day RM; Miki T; Burgess WH; Bottaro DP
    Biochemistry; 1999 Feb; 38(6):1765-71. PubMed ID: 10026256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paracrine effects of bFGF and KGF on the process of mouse blastocyst implantation.
    Taniguchi F; Harada T; Yoshida S; Iwabe T; Onohara Y; Tanikawa M; Terakawa N
    Mol Reprod Dev; 1998 May; 50(1):54-62. PubMed ID: 9547510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-affinity binding sites for related fibroblast growth factor ligands reside within different receptor immunoglobulin-like domains.
    Cheon HG; LaRochelle WJ; Bottaro DP; Burgess WH; Aaronson SA
    Proc Natl Acad Sci U S A; 1994 Feb; 91(3):989-93. PubMed ID: 8302878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor-mediated endocytosis of keratinocyte growth factor.
    Marchese C; Mancini P; Belleudi F; Felici A; Gradini R; Sansolini T; Frati L; Torrisi MR
    J Cell Sci; 1998 Dec; 111 ( Pt 23)():3517-27. PubMed ID: 9811566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratinocyte growth factor receptor ligands induce transforming growth factor alpha expression and activate the epidermal growth factor receptor signaling pathway in cultured epidermal keratinocytes.
    Dlugosz AA; Cheng C; Denning MF; Dempsey PJ; Coffey RJ; Yuspa SH
    Cell Growth Differ; 1994 Dec; 5(12):1283-92. PubMed ID: 7535082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the receptor for keratinocyte growth factor. Evidence for multiple fibroblast growth factor receptors.
    Bottaro DP; Rubin JS; Ron D; Finch PW; Florio C; Aaronson SA
    J Biol Chem; 1990 Aug; 265(22):12767-70. PubMed ID: 2165484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of fibroblast growth factor 9 (FGF9) as a high affinity, heparin dependent ligand for FGF receptors 3 and 2 but not for FGF receptors 1 and 4.
    Hecht D; Zimmerman N; Bedford M; Avivi A; Yayon A
    Growth Factors; 1995; 12(3):223-33. PubMed ID: 8619928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell type-specific inhibition of keratinocyte collagenase-1 expression by basic fibroblast growth factor and keratinocyte growth factor. A common receptor pathway.
    Pilcher BK; Gaither-Ganim J; Parks WC; Welgus HG
    J Biol Chem; 1997 Jul; 272(29):18147-54. PubMed ID: 9218449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer.
    Ishiwata T; Friess H; Büchler MW; Lopez ME; Korc M
    Am J Pathol; 1998 Jul; 153(1):213-22. PubMed ID: 9665482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a soluble KGF receptor cDNA from human corneal and breast epithelial cells.
    Liu JJ; Shay JW; Wilson SE
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2584-93. PubMed ID: 9856768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of keratinocyte growth factor on the proliferation and radiation survival of human squamous cell carcinoma cell lines in vitro and in vivo.
    Ning S; Shui C; Khan WB; Benson W; Lacey DL; Knox SJ
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):177-87. PubMed ID: 9422575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similarities and differences between the effects of heparin and glypican-1 on the bioactivity of acidic fibroblast growth factor and the keratinocyte growth factor.
    Berman B; Ostrovsky O; Shlissel M; Lang T; Regan D; Vlodavsky I; Ishai-Michaeli R; Ron D
    J Biol Chem; 1999 Dec; 274(51):36132-8. PubMed ID: 10593896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand binding by fibroblast growth factor receptors investigated using chimeric receptor molecules.
    Yayon A; Gray TE; Zimmer Y; Eisenstein M; Givol D
    J Recept Signal Transduct Res; 1995; 15(1-4):185-97. PubMed ID: 8903940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modeling based mutagenesis defines ligand binding and specificity determining regions of fibroblast growth factor receptors.
    Gray TE; Eisenstein M; Shimon T; Givol D; Yayon A
    Biochemistry; 1995 Aug; 34(33):10325-33. PubMed ID: 7544612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratinocyte growth factor is an important endogenous mediator of hair follicle growth, development, and differentiation. Normalization of the nu/nu follicular differentiation defect and amelioration of chemotherapy-induced alopecia.
    Danilenko DM; Ring BD; Yanagihara D; Benson W; Wiemann B; Starnes CO; Pierce GF
    Am J Pathol; 1995 Jul; 147(1):145-54. PubMed ID: 7604876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.